Prognostic value of ploidy, cell proliferation kinetics, and conventional clinicopathologic criteria in patients with colorectal carcinoma: A prospective study

Diseases of the Colon and Rectum

Volumn 39, Issue 5, 1996, Pages 494-503

  Pietra, Nicola ^a,b   Sarli, Leopolde ^a   Sansebastiano, Giuliano ^a   Jotti, Gloria Saccani ^a   Peracchia, Anacleto ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

Cell proliferation; Colorectal cancer; DNA; Flow cytometry; Labeling index; Ploidy; Prognostic factor

Indexed keywords

ADULT; AGED; CANCER STAGING; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONFERENCE PAPER; DNA CONTENT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLOIDY; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029920332     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02058700     Document Type: Conference Paper

References (64)

1. Dukes C. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323-32.
2. Cohen AM, Shank B, Friedman MA. Colorectal cancer. In: DeVita VI Jr, Hellmann S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: JB Lippincott, 1989:895-964.
3. Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 1984;37:961-74.
4. Hiddemann W, Von Bassewitz DB, Kleinemeier HJ, et al. DNA stemline heterogeneity in colorectal cancer. Cancer 1986;58:258-63.
5. Koss GK, Greenebaum L. Measuring DNA in humam cancer. JAMA 1986;255:3158-9.
6. Quirke P, Dyson JE. Flow cytometry: methodology and applications in pathology. J Pathol 1986;149:79-87.
7. Armitage NC, Robias RA, Evans DF, et al. The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985;72:828-30.
8. Melamed MR, Enker WE, Banner P, Janov AJ, Kessler G, Darzynkiewicz Z. Flow citometry of colorectal carcinoma with three year follow-up. Dis Colon Rectum 1986;29:184-6.
9. Frankfurt OS, Arbuck SG, Chin JL. Prognostic applications of DNA flow citometry for human solid tumors. Ann N Y Acad Sci 1986;87:276-290.
10. Kokal W, Sheibani K, Terz J, Harada R. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986;255:3123-7.
11. Goh HS, Jass JR, Atkin WS, Cuzick J, Northover JM. Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis. Int J Colorectal Dis 1987;2:17-21.
12. Emdin SO, Stenlig R, Roos G. Prognostic value of DNA content in colorectal carcinoma: a flow citometric study with some methodologic aspects. Cancer 1987;60: 1282-7.
13. Grandjouan S. Cancers colo-rectaux a l'heure de la genetique moleculaire. Presse Med 1994;23:929-30.
14. Gonzales Aguilera JJ, Fernandez-Peralta A, Vazquez R, Palicio M, Maillo C, Moreno Azcoita M. Genome instability in sporadic colorectal adenocarcinomas. Br J Surg 1994;81(Suppl 1):29.
15. Wolley RC, Schreiber K, Koss LG, et al. DNA distribution ln human colon carcinomas and its relationship to clinical behaviour. J Natl Cancer Inst 1982;69:15-22.
16. Quirke P, Dixon MF, Clayden AD, et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal carcinoma. J Pathol 1987;151:285-91.
17. Scott NA, Rainwater LM, Wieand HS, et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum 1987;30: 513-20.
18. Jones DJ, Moore M, Schofield PF. Refining the prognostic significance of DNA ploidy status in colorectal cancer: a prospective flow cytometric study. Int J Cancer 1988;41:206-10 .
19. Wiggers T, Arends JW, Schutte B, Volovics L, Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988;61: 386-95.
20. Halvorsen TB, Johanessen E. DNA ploidy, tumor site and prognosis in colorectal cancer. Scand J Gastroenterol 1990;25:141-8.
21. Jass JR, Mukawa K, Goh HS, Love SB, Cappellaro D. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J Clin Pathol 1989;42: 254-259.
22. Fisher ER, Sideritis RH, Sass R, Fisher B. Value of assessment of ploidy in rectal cancer. Int J Cancer 1990; 45:597-603.
23. Shackney SE, Smith CA, Miller BW, et al. Model for the genetic evolution of human solid tumors. Cancer Res 1898;49:3344-54.
24. Tribukait B, Hammarberg C, Rubio C. Ploidy and proliferation patterns in colorectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. Acta Pathol Microbiol Immunol Scand [A] 1983;91:89-95.
25. Morson BC, Sobin LH. Histological typing of intestinal tumors: international histological classification of tumors. Geneva: WHO, 1976:14.
26. Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the "no touch isolation" technique on survival rates. Ann Surg 1967;166:420-7.
27. Turnbull RB Jr. The no touch isolation technique of resection. JAMA 1975;231:1181-2.
28. Del Bino G, Silvestrini R, Zucconi MR, et al. DNA ploidy of human breast cancer. Ann Cell Pathol 1989;1:215-23.
29. Costa A, Faranda A, Scalman A, et al. Autoradiographic and flow cytometric assessment of cell proliferation in primary colorectal cancer: relationship to DNA ploidy and clinicopathological features. Int J Cancer 1992;50: 719-23.
30. Agresti A. Analysis of ordinal categorical data. New York: Wiley & Sons, 1984.
31. Cox DR. regression models and life tables. J R Stat Soc B 1972;34:187-220.
32. Valone F, Friedman M, Wittlinger P, et al. Treatment of patients with advanced colorectal carcinomas with fluouracil alone, high-dose leucovorin plus fluouracil or segmental methotrexate, fluouracil and leucovorin: a randomized trial of the Northern California Oncology Group. J Clin Oncol 1989;7:1427-36.
33. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264: 1444-50.
34. Moertel CG, Fleming TR, Mac Donald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
35. Krooke JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 1991;324:709-15.
36. Moertel CG, Fleming TR, Mac Donald JS, et al. The intergroup study of fluorouracile plus levamisole and levamisole alone as adjuvant therapy for stage C colon cancer: a final report. Pro ASCO 1992;11:161-6.
37. Peracchia A, Sarli L, Carreras F, Pietra N, Longinotti E, Gafà M. Recidive locoregionali dopo chirurgia curativa per cancro del colon. Ann Ital Chir 1991;1:37-44.
38. Peracchia A, Sarli L, Pietra N, Carreras F, Longinotti E, Gafà M. Recidive pelviche dopo chirurgia curativa per cancro del retto. Ann Ital Chir 1991;2:151-7.
39. Kirklin JW, Dockerty MB, Waugh JM. The role of peritoneal reflection in the prognosis of carcinoma of the rectum and sigmoid colon. Surg Gynecol Obstet 1949; 88:326-31.
40. Astler WB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-52.
41. Manual for staging of cancer. Chicago: American Joint Committee for cancer staging and end-results reporting, 1978.
42. Shein PS. Adjuvant chemotherapy and radiotherapy following rectal surgery: an interim report from the Gastrointestinal Tumor Study Group (GITSG). In: Jones SE, Salmon SE, eds. Adjuvant therapy of cancer III. New York: Grune and Stratton, 1981:547-58.
43. Newland RC, Chapuis PH, Pheils MT, MacPherson JC. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer 1981;47:1424-9.
44. Payne JE. International colorectal carcinoma staging and qradinq. Dis Colon Rectum 1989;32:282-5.
45. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, Kearney G, Fielding LP. Histopathology reporting in large bowel cancer. J Clin Pathol 1981;4:509-13.
46. Jass JR. Pathological staging: new methods and practical applications. Cancer Surv 1989;8:7-26.
47. Shapiro HM. Flow cytometry of DNA content and other indicators of proliferative activity. Arch Pathol Lab Med 1989;113:591-7.
48. Moran MR, Rothenberger DA, Gallo RA, Goldberg SM, James EC. Multifactorial analysis of local recurrences in rectal cancer, including DNA ploidy studies: a predictive model. World J Surg 1993;17:801-5.
49. Rognum TO, Thorud E, Lund E. Clinical behaviour in large bowel carcinoma patients with different DNA ploidy pattern [abstract]. Budapest: Atti XIV International Cancer Congress, 1986;2439.
50. Sasaki K, Hashimoto T, Kawachino K, Takahashi M. Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas. Cancer 1988;62:2569-75.
51. Deschner EE, Maskens AP. Significance of the labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals. Cancer 1982;50:1136-41.
52. Silvestrini R, Daidone MG, Valagussa P, Di Fronzo G, Mezzanotte G, Bonadonna G. Cell kinetics as a prognostic indicator in node-negative breast cancer. Eur J Cancer Clin Oncol 1989;25:1165-71.
53. Seckinger D, Sugarbaker E, Frankfurt O. DNA content in human cancer. Arch Pathol Lab Med 1980;113: 619-26.
54. 3H-Thymidine incorporation into polyps and adjacent mucosa. J Natl Cancer Inst 1966;36:849-55.
55. Bleiberg H, Mainguet P, Galnd P. Cell renewal in familiar polyposis: comparison between polyps and adjacent healthy mucosa. Gastroenterology 1972;63:240-5.
56. Lipkin M, Blattner WE, Fraumeni JF, Lynch HT, Deschner EE, Winawer S. Tritiated thymidine labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983;43:1899-1904.
57. Kanemitsu T, Koike A, Yamamoto S. Study of the cell proliferation kinetics in ulcerative colitis, adenomatous polyps and cancer. Cancer 1985;56:1094-8.
58. Lipkin M, Newmark MS. Effect of added dietary calcium on colonic epithelial cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985;33: 14381-4.
59. Bleiberg H, Buyse M, Galnd P. Cell kinetic indicators of premalignant stages of colorectal cancer. Cancer 1985; 56:124-9.
60. Silvestrini R, Faranda A, Costa A. DNA ploidy and cell kinetics in human colorectal carcinomas. J Surg Oncol 1991;2:4-8.
61. Silvestrini R, Costa A, Gennari L, Doci R, Bombardieri E, Bombelli L. Cell kinetics of hepatic metastases as prognostic marker in patients with advanced colorectal carcinoma. HPB Surg 1990;2:135-44.
62. Higgins GA, Lee CE, Dwight RW, Keehn RJ. The case for adjuvant 5FU in colorectal cancer. Cancer Clin Trails 1978;1:35-9.
63. Grace TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospective controlled randomized trial. Surg Clin North Am 1981;61: 1321-9.
64. Habib NA, Peck MA, Sawyer CN, Blaxland JW, Luck RJ. An analysis of the outcome of 301 malignant colorectal tumors. Dis Colon Rectum 1983;26:601-5.